Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …
BM Demaerschalk, DO Kleindorfer, OM Adeoye… - Stroke, 2016 - Am Heart Assoc
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical …
JA Frontera, JJ Lewin III, AA Rabinstein, IP Aisiku… - Neurocritical care, 2016 - Springer
Background The use of antithrombotic agents, including anticoagulants, antiplatelet agents,
and thrombolytics has increased over the last decade and is expected to continue to rise …
and thrombolytics has increased over the last decade and is expected to continue to rise …
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
E Berge, W Whiteley, H Audebert… - European stroke …, 2021 - journals.sagepub.com
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American …
Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …
management recommendations for evaluation and treatment of adults with acute ischemic …
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Background The aim of the Safe Implementation of Thrombolysis in Stroke-Monitoring Study
(SITS-MOST) was to assess the safety and efficacy of intravenous alteplase as thrombolytic …
(SITS-MOST) was to assess the safety and efficacy of intravenous alteplase as thrombolytic …
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
European Stroke Organisation (ESO) … - Cerebrovascular …, 2008 - karger.com
This article represents the update of the European Stroke Initiative Recommendations for
Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic …
Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic …
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
… (ESO) Executive Committee and the ESO … - Cerebrovascular …, 2008 - karger.com
This article represents the update of the European Stroke Initiative Recommendations for
Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic …
Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic …
Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence …
Objectives This article provides recommendations on the use of antithrombotic therapy in
patients with stroke or transient ischemic attack (TIA). Methods We generated treatment …
patients with stroke or transient ischemic attack (TIA). Methods We generated treatment …
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke
M Saqqur, K Uchino, AM Demchuk, CA Molina… - Stroke, 2007 - Am Heart Assoc
Background and Purpose—The objective of this study was to examine clinical outcomes and
recanalization rates in a multicenter cohort of stroke patients receiving intravenous tissue …
recanalization rates in a multicenter cohort of stroke patients receiving intravenous tissue …
[HTML][HTML] Neutrophil-to-lymphocyte ratio and symptomatic hemorrhagic transformation in ischemic stroke patients undergoing revascularization
M Świtońska, N Piekuś-Słomka, A Słomka, P Sokal… - Brain Sciences, 2020 - mdpi.com
Objectives: Symptomatic hemorrhagic transformation (sHT) is a life-threatening complication
of acute ischemic stroke (AIS). The early identification of the patients at increased risk of sHT …
of acute ischemic stroke (AIS). The early identification of the patients at increased risk of sHT …